期刊文献+

多囊平胶囊治疗多囊卵巢综合征的实验研究 被引量:4

Treatment of polycystic ovary syndrome with duonangping capsule in rats
下载PDF
导出
摘要 目的 探讨中药多囊平胶囊对 (DNP)多囊卵巢 (PCO)大鼠的治疗作用及作用机制。方法 运用放免法测定多囊平治疗前后血睾酮 (testosterone ,T)、胰岛素 (insulin ,INS)、口服糖耐量实验 (OGTT)中胰岛素曲线下面积及血瘦素 (leptin)水平的变化 ;连续阴道涂片观察各组大鼠排卵情况的变化。结果 多囊平胶囊使PCO大鼠血T、leptin均明显下降 ,并且OGTT实验中曲线下面积减小。用药后大鼠体重明显降低。经治疗PCO多囊平组 3只大鼠恢复排卵。结论 多囊平胶囊可用于临床治疗高雄激素血症。说明在多囊卵巢综合征 (PCOS)高雄激素形成中除INS作用外尚有其他关键因素作用。多囊平在中枢及外周协调发挥作用调整能量失衡和性腺功能 ,进一步体现了中医药的整体治疗作用。 Objective To investigate the effects of duonangping (DNP) on rats with polycystic ovary and to explore the possible mechanism. Methods The levels of serum testosterone,insulin, and leptin were detected by radioimmunoassay, and the total areas under insulin tolerance curves were calculated.Vaginal smears were daily made to evaluate individual ovulation changes. Results The levels of of serum testosterone and leptin decreased obviously in DNP-recieved rats with PCO.The total areas under insulin tolerance curves in PCO rats were significantly higer than those in combined treatment rats, and the rat weight all reduced. Conclusion DNP capsule can decrease the level of serum testostrone , so it can be used to treat the hyperandrogenism.DNP has also some important roles in PCOS besides the action of insulin.
出处 《山西医科大学学报》 CAS 2003年第5期447-450,共4页 Journal of Shanxi Medical University
关键词 多囊平胶囊 治疗 多囊卵巢综合征 实验研究 polycystic ovary syndrome hyperinsulinism insulin resistance hyperandrogenism phitotherapy duonangping capsule
  • 相关文献

参考文献11

  • 1王蔼明,卢春华,乔杰,李美芝.人绒毛膜促性腺激素和胰岛素对多囊卵巢综合征卵泡内膜细胞雄激素分泌的影响[J].中华妇产科杂志,1998,33(5):280-283. 被引量:18
  • 2Moson H, Franks S. Local control of ovarian steroidogenenesis [J]. Bailliere' s Clin Obstet Gynecol, 1997,11:261 - 279.
  • 3Netsler JE, Jakubowicz DJ, Evens WS, et al. Effects of metformin on spontaneous and clomiphene-induced ovulation in the Polycystic Ovary Syndrome[J]. New Engl J Med, 1998, 338:1876 - 1880.
  • 4Poretsky L, Clemons J, Bogovih K. Hyperinsulinemia and human chorionic gonadotropin synergistically promote the growth of ovarian follicular cysts in rats[J]. Metabolism, 1992,41(8):903-910.
  • 5Kava R, West DB, Lukasik VA, et al. Sexual dimorphism of hyperglycemia and glucose tolerance in Wistar fatty rats[J ]. Diabetes, 1989 , 38 : 159- 163.
  • 6Holte J. Polycystic ovary syndrome and insulin resistance ; thrity genesstruggling with overfeeding and sedentary lifestyle [J ]? J Endocrinol Invest , 1998 , 21(9):589-601.
  • 7Prelevic GM. Insulin Resistance in Polycystic Ovary Syndrome[J]. Curr Opin Obstet Gynecol, 1997, 9(3) : 193 -201.
  • 8Nestler JE. Role of hyperinsulinemia in the pathogenesis of polycystic ovary syndrome and its clinical implication[J]. Semia Reprod Endocrinol, 1997, 15 : 111 - 122.
  • 9Velazquez EM, Mandoza S, Hamer T, et al. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, whilefacilitating normalmenses and pregnancy[J], metabolism, 1994, 43 :647 - 654.
  • 10Cuai K, Defronza RA. Metfirmin: a review of its metabolic effects[J]. Diabetes Reviews, 1998, 6(2) : 89- 131.

共引文献17

同被引文献43

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部